Scarica l'app Stockscreener
21.38
0.09%
0.02
Dopo l'orario di chiusura:
21.38
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$21.36
Aprire:
$21.36
Volume 24 ore:
338.73K
Relative Volume:
0.70
Capitalizzazione di mercato:
$970.01M
Reddito:
$719.89M
Utile/perdita netta:
$98.09M
Rapporto P/E:
10.51
EPS:
2.0334
Flusso di cassa netto:
$118.98M
1 W Prestazione:
+3.89%
1M Prestazione:
+17.60%
6M Prestazione:
-10.39%
1 anno Prestazione:
-12.45%
Intervallo 1D:
$21.11
$21.70
Intervallo di 1 settimana:
$20.14
$21.70
Portata 52W:
$17.03
$31.26
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
21.38 | 924.19M | 719.89M | 98.09M | 118.98M | 2.0334 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.74 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2025-08-12 | Aggiornamento | Needham | Hold → Buy |
| 2025-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Amphastar Pharmaceuticals, Inc. ($AMPH) CEO 2025 Pay Revealed - Quiver Quantitative
Amphastar (NASDAQ: AMPH) outlines 2026 virtual meeting, director and pay votes - Stock Titan
Do options traders know something about Amphastar Pharmaceuticals stock we don't? - MSN
How The Story Is Shifting For Amphastar Pharmaceuticals (AMPH) After Guidance Cut And New Launches - Yahoo Finance
AMPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Barclays Lowers Price Target for Amphastar Pharma (AMPH) | AMPH Stock News - GuruFocus
Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Lowered to $23.00 at Barclays - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Given Average Rating of "Hold" by Brokerages - MarketBeat
Understanding Momentum Shifts in (AMPH) - Stock Traders Daily
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference - ACCESS Newswire
Amphastar CFO, regulatory chief to present April 14; replay lasts 30 days - Stock Titan
Amphastar Pharmaceuticals, Inc. (AMPH) stock price, news, quote and history - Yahoo Finance Australia
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
AMPH Earning Date, Earning Analysis and Earning Prediction - intellectia.ai
SG Americas Securities LLC Makes New Investment in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharma (AMPH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo! Finance Canada
Amphastar Pharmaceuticals, Inc. (AMPH) Stock forecasts - Yahoo Finance UK
Amphastar Pharmaceuticals (NASDAQ:AMPH) Share Price Passes Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Vanguard reports 0 shares of Amphastar (amendment) | AMPH SEC FilingForm SCHEDULE 13G/A - Stock Titan
Volume Recap: Is Amphastar Pharmaceuticals Inc forming a double bottom2026 Volatility Report & High Accuracy Swing Trade Signals - baoquankhu1.vn
Portfolio Update: Is Amphastar Pharmaceuticals Inc backed by strong institutional buyingPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Outlook: Can Amphastar Pharmaceuticals Inc stock outperform in a bear marketWeekly Investment Recap & AI Driven Price Forecasts - baoquankhu1.vn
Stock Market Recap: Is Amphastar Pharmaceuticals Inc a potential multi bagger2026 Volatility Report & Fast Gaining Stock Reports - baoquankhu1.vn
Amphastar (AMPH) EVP Yakob has 1,033 shares withheld for RSU tax - Stock Titan
[Form 4] Amphastar Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Tax withholding trims Amphastar (NASDAQ: AMPH) exec's RSU shares - Stock Titan
Tax withholding on RSU vesting for Amphastar (AMPH) CFO Peters - Stock Titan
Discipline and Rules-Based Execution in AMPH Response - Stock Traders Daily
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
NeoGenomics, Natera, and Amphastar Pharmaceuticals shares skyrocket, what you need to know - MSN
Amphastar Pharmaceuticals Inc authorizes $50 million increase to share buyback program on March 12, 2026SEC filing - marketscreener.com
Amphastar Pharmaceuticals IncAuthorizes $50 Million Increase To Share Buyback Program On March 12, 2026SEC Filing - TradingView
Amphastar Expands Share Repurchase Authorization to Manage Equity - TipRanks
Amphastar Pharmaceuticals boosts buyback program by $50 million - TradingView
Amphastar (NASDAQ: AMPH) adds $50 million to share buyback program - Stock Titan
Clark Capital Management Group Inc. Invests $7.56 Million in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Algert Global LLC Acquires 268,612 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals: Why I Like Bull Put Options Strategy Here (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Hold" from Analysts - MarketBeat
Amphastar reports FDA approval for teriparatide injection - MSN
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare ConferenceSlideshow - Seeking Alpha
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month LowShould You Sell? - MarketBeat
Amphastar (AMPH) CFO granted RSUs, stock options and withholds shares for taxes - Stock Titan
Risk Report: Can Amphastar Pharmaceuticals Inc maintain its current growth rateRate Hike & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Amphastar (AMPH) exec granted RSUs, options and reports tax share withholding - Stock Titan
Amphastar (NASDAQ: AMPH) EVP receives RSUs and stock option grant - Stock Titan
Equity awards and tax withholding for Amphastar Pharmaceuticals (AMPH) insiders - Stock Titan
Amphastar (AMPH) CFO Peters reports 2,146-share tax-withholding on RSU vesting - Stock Titan
Amphastar (AMPH) CEO logs 10,850-share RSU tax withholding, retains large stake - Stock Titan
Amphastar Pharmaceuticals : Barclays 28th Annual Global Healthcare Conference Presentation - marketscreener.com
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Amphastar Pharmaceuticals Inc Azioni (AMPH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 17 '25 |
Sale |
26.20 |
9,787 |
256,379 |
138,043 |
| Petersen Floyd F. | Director |
Dec 12 '25 |
Sale |
25.92 |
2,426 |
62,888 |
71,368 |
| Petersen Floyd F. | Director |
Dec 11 '25 |
Sale |
25.69 |
1,737 |
44,620 |
73,794 |
1.06%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):